Teva Branded Pharmaceutical Products R&D, Inc.

An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy

Phase 2Recruiting2025200 people29 Sept 2025clinicaltrials.gov

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

CollaboratorPhase 3Completed2021332 people28 Jan 2021clinicaltrials.gov

NCT04392648

Phase 1Withdrawn20200 people19 May 2020clinicaltrials.gov

NCT03215030

Phase 1/2Terminated2017272 people12 Jul 2017clinicaltrials.gov

NCT01903824

Phase 1Completed201340 people19 Jul 2013clinicaltrials.gov

NCT01348919

Phase 1/2Completed201111 people6 May 2011clinicaltrials.gov

NCT01265849

CollaboratorPhase 3Completed2010928 people23 Dec 2010clinicaltrials.gov

NCT01188187

CollaboratorPhase 3Completed20101,022 people25 Aug 2010clinicaltrials.gov

NCT01187888

CollaboratorPhase 3Terminated201044 people24 Aug 2010clinicaltrials.gov

NCT01126190

Phase 3Completed2010381 people19 May 2010clinicaltrials.gov

NCT00877006

Phase 3Completed2009447 people7 Apr 2009clinicaltrials.gov

NCT00837265

Phase 2/3Completed2008334 people5 Feb 2009clinicaltrials.gov

NCT00203112

Phase 2Completed200444 people20 Sept 2005clinicaltrials.gov

NCT00203099

Phase 2Completed200418 people20 Sept 2005clinicaltrials.gov